Is HYFT or IBIO more undervalued in 2026?

CirclFi compares MindWalk Holdings Corp. (HYFT) and iBio, Inc. (IBIO) using 13 institutional-grade valuation models. HYFT has a Quality of Company score of 1.7/10 while IBIO scores 3.6/10.

Which is a better buy — HYFT or IBIO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do HYFT and IBIO valuations compare?

HYFT at $1.76 and IBIO at $1.90 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

HYFT vs IBIO Valuation Comparison 2026 — Intrinsic Value Analysis

HYFT

Pharmaceutical Preparations

MindWalk Holdings Corp.

Quality

1.7

out of 10

Value Trap

—

Price

$1.76

Last close

Models

8/13

Active

IBIO

Pharmaceutical Preparations

iBio, Inc.

Quality

3.6

out of 10

Value Trap

SAFE

Price

$1.90

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	HYFT Fair Value	HYFT Upside	IBIO Fair Value	IBIO Upside
Bayesian DCF	Intrinsic	$0.42	-75.9%	$0.99	-47.8%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.12	-90.6%	$1.08	-43.1%
PWERM	Option-Based	$1.40	-20.7%	$1.80	-5.4%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for HYFT vs IBIO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HYFT vs IBIO — Which Stock Is More Undervalued?

IBIO scores higher with a 3.6/10 quality rating vs HYFT's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing MindWalk Holdings Corp. (HYFT) and iBio, Inc. (IBIO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HYFT currently trades at $1.76 with a QOC of 1.7/10, while IBIO trades at $1.90 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).